匹伐他汀杂质列表  深圳远扬化学技术有限公司主营医药标准品及杂质对照品，以下杂质备有库存，可当天发货，*：匹伐他汀杂质，曲氟尿苷杂质，依鲁替尼杂质，奥贝胆酸杂质，依美斯汀杂质，卡格列净杂质，利格列汀杂质，西格列汀杂质，埃索美拉唑杂质，LCZ696杂质，恩杂鲁胺杂质，艾曲波帕杂质，非布司他杂质，托匹司他杂质，乐伐替尼杂质，奥拉帕尼杂质，阿维巴坦杂质，奥美拉唑杂质，普卡必利杂质，西他沙星杂质，泊沙康唑杂质，替格瑞洛杂质，托法替尼杂质，决奈达隆杂质，阿奇霉素杂质等。

匹伐他汀钙背景及前程：

冠心病是威胁人类健康和生命的常见病和多发病，以低密度脂蛋白(LDL)升高为特征的高胆固醇血症则是诱发冠心病的主要危险因子之一。常用的降血脂药如烟酸类、树脂类或贝特类等疗效都难尽人意，降脂作用的是被称为他汀类(statins)的药物。他汀类药物共同的作用机制是都属于3—羟—3—甲基—戊二酰辅酶A(HMG—CoA)还原酶抑制剂，目前在世界广泛应用的主要有6种：洛伐他汀(lovastatin)，普伐他汀(pravastatin)，辛伐他汀(simvastatin)，西立伐他汀(cerivastatin)，氟伐他汀(fluvastatin)和阿托伐他汀(atorvastatin)。而近期由Kowa公司开发的新型他汀类药物匹他伐他汀钙，因其良好的降胆固醇作用而被称为“超级他汀类药物”(Superstatin)。

匹伐他汀杂质列表（具体结构式见附件）

（若列表中无您需要的杂质，欢迎详询我司，我司可提供杂质定制服务，货期短，到货快）

Pitavastatin

(+)-Monocalcium bis{(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate}

Pitavastatin Impurity 1

(3R,6E)-7-[2-cyclopropyl-4-(4-flurophenyl)-3-quinolinyl]-3-hydroxy-5-oxo-6-heptenoate

Pitavastatin Impurity 2

(3S,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid calcium salt

Pitavastatin Impurity 3

(4R,6S,E)-6-[2-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl] vinyl] tetrahydro-4-hydroxypyran-2-one

Pitavastatin Impurity 4

7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic Acid

Pitavastatin Impurity 5

(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid calcium salt

Pitavastatin Impurity 6

(3S,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid calcium salt

Pitavastatin Impurity 7

(3R,5S,6E)-7-[2-Cyclopropyl-4-phenyl-quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid calcium salt

Pitavastatin Impurity 8

 [[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]methyl]triphenyl-phosphonium Bromide

Pitavastatin Impurity 9

(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-quinolin-3-yl]-2,2-dimethyl-1,3-dioxane-6-heptenoic acid t-butyl ester

Pitavastatin Impurity 10

(3R,5S,E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxy-N-(1-phenylethyl)hept-6-enamide

Pitavastatin Impurity 11

Sodium (5S, 6E)-7-[2-cyclopropyl-4-(4-flurophenyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoate

Pitavastatin Impurity 12

Ethyl (3R, 6E)-7-[2-cyclopropyl-4-(4-flurophenyl)-3- quinolinyl]-3-hydroxy-5-oxo-6-heptenoate

Pitavastatin Impurity 13

Ethyl (5S, 6E)-7-[2-cyclopropyl-4-(4-flurophenyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoate

Pitavastatin Impurity 14

(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid methyl ester

Pitavastatin Impurity 15

(3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid ethyl ester

Pitavastatin Impurity 16

(3R,5S)-5-(6-Cyclopropyl-10-fluoro-7,8-dihydrobenzo[k]phenanthridin-8-yl)-3,5-dihydroxypentanoic acid sodium salt

Pitavastatin Impurity 17

2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinemethanol

Pitavastatin Impurity 18

(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid ethyl ester

Pitavastatin Impurity 19

(3S,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid ethyl ester

Pitavastatin Impurity 20

(3S,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid ethyl ester

Pitavastatin Impurity 21

(3R,5S,6E)-7-(2-Cyclopropyl-4-phenyl-3-quinolinyl)-3,5-dihydroxy-6-heptenoic Acid tert-Butyl Ester

Pitavastatin Impurity 22

2-((4R,6S)-6-((E)-2-(2-Cyclopropyl-4-phenylquinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic Acid tert-Butyl Ester